Power Law company profile

CTI Biopharma (Formerly Cell Therapeutics)

Biotech & Life Sciences · Seattle, United States · Founded 1992 · IPO 1997 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.19B

Market cap · 2026

Revenue

$54M

Latest reported FY

Global footprint

Where CTI Biopharma (Formerly Cell Therapeutics) has talent and traffic

Web traffic by country

730 monthly visits
across markets

🏳️ Russian Federation95.9%

Top 1 markets shown

Patent intelligence

$11M patent portfolio · 8 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$11M

0.95% of market cap · 178.4× smaller than top peer Ablynx ($2B)

8 active patent families

Where CTI Biopharma (Formerly Cell Therapeutics) innovates Molecular biologyMedicinal chemistryPhosphatidic acidAmino radicalDisease

Below peer median on Legal, Strategic, Market, Technology

Quality vs same-sector peers

CTI Biopharma (Formerly Cell Therapeutics) on the five Patsnap quality dimensions

CTI Biopharma (Formerly Cell Therapeutics) in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where CTI Biopharma (Formerly Cell Therapeutics) concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across CTI Biopharma (Formerly Cell Therapeutics) and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See CTI Biopharma (Formerly Cell Therapeutics) on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo